Lacryvisc 0.3 % (DIN 02236907) — Cancelled Pre Market in Canada

Q: Is Carbomer registered outside Canada?

Yes — 47 matched registrations in 14 other markets.

Lacryvisc 0.3 % Gel is a Health Canada–registered human drug (DIN 02236907) held by Alcon Canada Inc, containing Carbomer. Health Canada lists its status as Cancelled Pre Market (status date 25 Jun 2021). Nexara Health has matched 47 registrations of Carbomer across 14 other regulated markets.

Health Canada registration

DIN	02236907
Brand name	Lacryvisc
Active ingredient	Carbomer
Strength	0.3 %
Dosage form	Gel
Route	Ophthalmic
Company	Alcon Canada Inc
Status	Cancelled Pre Market — 25 Jun 2021
Class	Human
ATC
AHFS	20:12.04.16
Regulator record	Health Canada DPD entry · Product monograph

Carbomer registered in other markets

47 registrations of the same molecule in 14 national registries outside Canada (first 46 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

Country	Product	Marketing authorisation holder	Strength	Form	Status	Registry
Argentina	Acrylarm Plus	Poen	gel oft.x 10 g		Listed	PAMI
Argentina	Cool Gel	Max Vision	gel oft.x 10 g		Listed	PAMI
Argentina	Ph Lagrimas Gel	Elea	gel oft.x 10 ml		Listed	PAMI
Argentina	Xicrim	Lab Internacion	fco. got.x 10 g		Listed	PAMI
Australia	Optifresh eye gel	Pp		Eye gel 2 mg per g, 10 g	GE	PBS
Australia	Optifresh eye gel	Pp		Eye gel 2 mg per g, 10 g	GE	PBS
Australia	Paa	Ul		Eye gel 2 mg per g, 10 g	GE	PBS
Australia	Viscotears Gel PF	Uo		Eye gel 2 mg per g, single dose units 0.6 mL, 30	GE	PBS
Australia	Viscotears Gel PF	Uo		Eye gel 2 mg per g, single dose units 0.6 mL, 30	GE	PBS
Australia	Viscotears Gel PF	Uo		Eye gel 2 mg per g, single dose units 0.6 mL, 30	GE	PBS
Bahrain	Liposic	Dr. Gerhard Mann Chem.-Pharm. Fabrik GmbH, Germany.	2 MG/G	Eye Gel	POM	NHRA
Brazil	Vidisic Gel	Bl Indústria Otica Ltda	2 MG/G GEL OFT CT TB PLAS PEAD OPC X 10 G		Específico	CMED
Denmark	Lakrimont	Laboratoires Thea S.A.S.	2 mg/g	øjengel	MRP	Laegemiddelstyrelsen
Denmark	Visc-ophtal	Orifarm A/S	2 mg/g	øjengel	Par-Imp	Laegemiddelstyrelsen
Denmark	Viscotears	Dr. Gerhard Mann Chem.-pharm. Fabrik GmbH	2 mg/g	øjengel, enkeltdosisbeholder	National	Laegemiddelstyrelsen
Denmark	Viscotears	2care4 ApS	2 mg/g	øjengel, enkeltdosisbeholder	Par-Imp	Laegemiddelstyrelsen
Denmark	Viscotears	2care4 ApS	2 mg/g	øjengel	Par-Imp	Laegemiddelstyrelsen
Denmark	Viscotears	Paranova Danmark ApS	2 mg/g	øjengel	Par-Imp	Laegemiddelstyrelsen
Denmark	Viscotears	Dr. Gerhard Mann Chem.-pharm. Fabrik GmbH	2 mg/g	øjengel	National	Laegemiddelstyrelsen
Dominican Republic	Carbomer	Atlas Farmaceutica S.a., Argentina			Registered	MISPAS
Hong Kong	Liposic Eye Gel 0.2%	Bausch & Lomb (Hk) Ltd			Registered	DH Drug Office
Hong Kong	Siccapos Eye Gel 2mg/g	Reich Pharm Limited			Registered	DH Drug Office
Ireland	Geltears 0.2 % w/w carbomer eye gel	Bausch + Lomb Ireland Limited		Eye gel	Marketed	HPRA
Ireland	Liposic 2 mg/g eye gel	Bausch + Lomb Ireland Limited		Eye gel	Marketed	HPRA
Ireland	LIQUIVISC 2.5 mg/g eye gel	Laboratoires Thea		Eye gel	Marketed	HPRA
Ireland	Vidisic 0.2 % w/w eye gel	Bausch + Lomb Ireland Limited		Eye gel	Marketed	HPRA
Ireland	Vidisic Preservative Free Single Dose Unit	Bausch + Lomb Ireland Limited		Eye gel	Marketed	HPRA
Italy	SICCAFLUID*gel oftalmico 30 monodosi 0,5 g 2,5 mg/g	THEA FARMA SpA	CARBOMER 0,5G 30 UNITA' GEL USO OFTALMICO		Classe A	AIFA liste A/H
Poland	Oftagel	Santen Oy	2,5 mg/g	Żel do oczu	Bezterminowe	URPL RPL
Poland	Vidisic	Medezin Sp. z o.o.	2 mg/g	Żel do oczu	2025-06-22	URPL RPL
Poland	Vidisic	InPharm Sp. z o.o.	2 mg/g	Żel do oczu	2026-12-22	URPL RPL
Poland	Vidisic	Delfarma Sp. z o.o.	2 mg/g	Żel do oczu	2027-10-24	URPL RPL
Poland	Vidisic	Delfarma Sp. z o.o.	2 mg/g	Żel do oczu	2031-08-03	URPL RPL
Poland	Vidisic	Dr Gerhard Mann Chem. - Pharm. Fabrik GmbH	2 mg/g	Żel do oczu	Bezterminowe	URPL RPL
Poland	Vidisic	InPharm Sp. z o.o.	2 mg/g	Żel do oczu	2028-07-18	URPL RPL
Poland	Vidisic	Aga Kommerz spol. s r.o.	2 mg/g	Żel do oczu	2027-03-28	URPL RPL
Saudi Arabia	Artelac Night Time Gel	—	2		Inactive	SFDA
Saudi Arabia	Viscotears Opth.gel	—	2		Inactive	SFDA
Taiwan	Vicemer Eye Gel 0.2%(Carbomer)	景德製藥股份有限公司桃園廠		眼用凝膠劑	Registered	TFDA
United Arab Emirates	Carbogel Eye Gel Drops	HANOI CPC1 PHARMACEUTICAL JOINT STOCK COMPANY, Vietnam, Hanoi	0.2%	Drops	Active	EDE
United Arab Emirates	LipoMer Eye Drops	COC FARMACEUTICI S.r.l, Italy, Sant Agata Bolognese	0.2%	Drops	Active	EDE
United Arab Emirates	LipoMer Eye Drops	COC FARMACEUTICI S.r.l, Italy, Sant Agata Bolognese	0.2%	Drops	Active	EDE
United Arab Emirates	Optilux	COC FARMACEUTICI S.r.l, Italy, Sant Agata Bolognese	0.2%	Drops	Active	EDE
United Kingdom	Carbomer 0.35% eye gel	—			0001	NHS dm+d VMP
United Kingdom	Carbomer 0.36% eye gel preservative free	—			0001	NHS dm+d VMP
United Kingdom	Carbomer 974P 0.25% eye gel	—			0001	NHS dm+d VMP

See every manufacturer of Carbomer worldwide →

Regulator price references for Carbomer

Published list or reimbursement prices for Carbomer presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Country	Product	Strength	Pack	Price	Type	Source	As of
Australia	Viscotears		Eye gel 2 mg per g, 10 g	3.12 AUD	ex-manufacturer	PBS	2026-09-08
Australia	Viscotears		Eye gel 2 mg per g, 10 g	3.12 AUD	ex-manufacturer	PBS	2026-09-08
Australia	Optifresh eye gel		Eye gel 2 mg per g, 10 g	3.12 AUD	ex-manufacturer	PBS	2026-09-08
Australia	Viscotears Gel PF		Eye gel 2 mg per g, single dose units 0.6 mL, 30	5.48 AUD	ex-manufacturer	PBS	2026-09-08
Australia	Viscotears Gel PF		Eye gel 2 mg per g, single dose units 0.6 mL, 30	5.48 AUD	ex-manufacturer	PBS	2026-09-08
Australia	Viscotears Gel PF		Eye gel 2 mg per g, single dose units 0.6 mL, 30	5.48 AUD	ex-manufacturer	PBS	2026-09-08
Bahrain	Liposic	2mg/1000mg	10G	1.42 BHD	retail (max)	NHRA	2026-09-01
Brazil	Vidisic Gel	2mg/1000mg	2 MG/G GEL OFT CT TB PLAS PEAD OPC X 10 G	34.76 BRL	preco fabrica (ex-factory ceiling)	CMED	2026-09-02
Italy	SICCAFLUID*gel oftalmico 30 monodosi 0,5 g 2,5 mg/g	500mg	CARBOMER 0,5G 30 UNITA' GEL USO OFTALMICO	5.71 EUR	prezzo al pubblico (classe A)	AIFA liste A/H	2026-09-02
Saudi Arabia	Viscotears Opth.gel			17.40 SAR	public	SFDA	2026-09-01
Saudi Arabia	Artelac Night Time Gel			30.10 SAR	public	SFDA	2026-09-01
United Arab Emirates	Carbogel Eye Gel Drops	0.2pct	20’s [20x0.6g Reclosable Vials]	82.00 AED	public	EDE	2026-08-31
United Arab Emirates	Optilux	0.2pct	20’s [20x0.6ml Single-dose Vials]	88.00 AED	public	EDE	2026-08-31
United Arab Emirates	LipoMer Eye Drops	0.2pct	20’s [20x0.5ml Single-dose Vials]	89.50 AED	public	EDE	2026-08-31
United Arab Emirates	LipoMer Eye Drops	0.2pct	30’s [30x0.5ml Single-dose Vials]	133.50 AED	public	EDE	2026-08-31

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Lacryvisc (DIN 02236907) marketed in Canada?

No. Health Canada lists DIN 02236907 as Cancelled Pre Market as of 25 Jun 2021.

Who holds the Canadian licence for this product?

Alcon Canada Inc is the company of record in the Health Canada Drug Product Database.

Is Carbomer registered outside Canada?

Yes — Nexara Health has matched 47 registrations in 14 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02236907, status date 2021-06-25; national medicine registries: AIFA liste A/H, CMED, DH Drug Office, EDE, HPRA, Laegemiddelstyrelsen, MISPAS, NHRA, NHS dm+d VMP, PAMI, PBS, SFDA, TFDA, URPL RPL; price sources: AIFA liste A/H, CMED, EDE, NHRA, PBS, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02236907, status date 2021-06-25; national medicine registries: AIFA liste A/H, CMED, DH Drug Office, EDE, HPRA, Laegemiddelstyrelsen, MISPAS, NHRA, NHS dm+d VMP, PAMI, PBS, SFDA, TFDA, URPL RPL; price sources: AIFA liste A/H, CMED, EDE, NHRA, PBS, SFDA.

Alcon Canada Inc — company profile Who else makes Carbomer All Canadian Carbomer products

Health Canada Drug Product Database (DPD), DIN 02236907, status date 2021-06-25; national medicine registries: AIFA liste A/H, CMED, DH Drug Office, EDE, HPRA, Laegemiddelstyrelsen, MISPAS, NHRA, NHS dm+d VMP, PAMI, PBS, SFDA, TFDA, URPL RPL; price sources: AIFA liste A/H, CMED, EDE, NHRA, PBS, SFDA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.